Emily Sciortino

Accomplished biopharmaceutical analytical development and quality control leader with 15 years’ experience driving end to end analytical control strategy, method development, validation and regulatory submission activities for biologics. Extensive experience overseeing CMC analytical work across early and late-stage development for various modalities including monoclonal antibodies, complex fusion proteins and bispecifics. Well-versed with internal and external global QC network management, including CDMO and CLO relationships, method/technology transfers, and ensuring GxP compliance. My passion is transforming drug development using automation tools and platform methodologies to support efficient, high-quality analytical execution.